Current Challenges In Personalized Cancer Medicine by Keiran Smalley

Current Challenges In Personalized Cancer Medicine

byKeiran SmalleyEditorKeiran Smalley

Hardcover | September 26, 2012

not yet rated|write a review

Pricing and Purchase Info

$346.23 online 
$415.07
Earn 1731 plum® points

In stock online

Ships free on orders over $25

Not available in stores

about

For this volume ofAdvances in Pharmacologywe have brought together some of the foremost basic science and clinical researchers to discuss some of the new frontiers in the development of targeted cancer therapy. Although still in its formative stages, the development of targeted cancer therapies has already shown incredible promise in a limited number of cancer types. As basic cancer research and drug development continues, we expect this number to grow and more patients to benefit from these exciting advances. Through better patient selection and novel strategies to manage resistance, a future can be envisaged in which cancer can be reduced to the level of a chronic, manageable disease.



  • Brought together some of the foremost basic science and clinical researchers
  • Part of the renowned Advances in Pharmacology Serial
  • Discussion of some of the new frontiers in the development of targeted cancer therapy

Details & Specs

Title:Current Challenges In Personalized Cancer MedicineFormat:HardcoverDimensions:576 pages, 9 × 6 × 0.98 inPublished:September 26, 2012Publisher:Academic PressLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:0123979277

ISBN - 13:9780123979278

Look for similar items by category:

Customer Reviews of Current Challenges In Personalized Cancer Medicine

Reviews

Extra Content

Table of Contents

  1. Vertical pathway targeting in cancer therapy
  2. Histone Deacetylases (HDACs) as Mediators of Resistance to Apoptosis in Melanoma and as Targets for Combination Therapy with Selective BRAF Inhibitors
  3. Targeting the tumor stroma as a novel treatment strategy for breast cancer - shifting from the neoplastic cell-centric to a stroma-centric paradigm
  4. Targeting the Metabolic Microenvironment of Tumors
  5. Targeted Therapy for Matastasis
  6. Emerging Strategies for Targeting Cell Adhesion in Multiple Myelom
  7. Targeting Notch Signaling for Cancer Therapeutic Intervention
  8. Stem-like cells and therapy resistance in squamous cell carcinomas
  9. Targeting the tumor stroma as a novel therapeutic approach for prostate cancer
  10. Resistance to chemotherapy: short-term drug tolerance and stem cell-like subpopulations
  11. Intratumoral Heterogeneity as a Therapy Resistance Mechanism: Role of Melanoma Subpopulations
  12. Chemoprevention of Melanoma
  13. Whole genome and exome sequencing of melanoma: a step toward personalised targeted therapy
  14. Targeted Therapy for Gastric Adenocarcinoma
  15. HSP90 Inhibitors for Cancer Therapy and Overcoming Drug Resistance
  16. Apoptosis in Targeted Therapy Responses: The Role of BIM